These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9376599)
1. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Salven P; Teerenhovi L; Joensuu H Blood; 1997 Oct; 90(8):3167-72. PubMed ID: 9376599 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Salven P; Orpana A; Teerenhovi L; Joensuu H Blood; 2000 Dec; 96(12):3712-8. PubMed ID: 11090051 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma. Niitsu N; Okamato M; Nakamine H; Yoshino T; Tamaru J; Nakamura S; Higashihara M; Hirano M Eur J Haematol; 2002 Feb; 68(2):91-100. PubMed ID: 12038454 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Bono P; Teerenhovi L; Joensuu H Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089 [TBL] [Abstract][Full Text] [Related]
5. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Salven P; Ruotsalainen T; Mattson K; Joensuu H Int J Cancer; 1998 Apr; 79(2):144-6. PubMed ID: 9583728 [TBL] [Abstract][Full Text] [Related]
6. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Gunsilius E; Petzer AL; Gastl G Br J Haematol; 2000 Mar; 108(3):661-3. PubMed ID: 10847704 [No Abstract] [Full Text] [Related]
7. Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Bondestam J; Salven P; Jääskela-Saari H; Ikonen T; Lepäntalo M; Mattila S; Joensuu H Am J Surg; 2000 Jan; 179(1):57-9. PubMed ID: 10737580 [TBL] [Abstract][Full Text] [Related]
8. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609 [TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991 [TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation. Tuttle RM; Fleisher M; Francis GL; Robbins RJ J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308 [TBL] [Abstract][Full Text] [Related]
14. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. Salven P; Teerenhovi L; Joensuu H Blood; 1999 Nov; 94(10):3334-9. PubMed ID: 10552942 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of vascular endothelial growth factor in patients with head and neck cancer. Riedel F; Götte K; Schwalb J; Wirtz H; Bergler W; Hörmann K Eur Arch Otorhinolaryngol; 2000; 257(6):332-6. PubMed ID: 10993554 [TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ; Li JR; Li ZB Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) serum concentration changes during chemotherapy in patients with lung cancer. Kido Y Kurume Med J; 2001; 48(1):43-7. PubMed ID: 11402619 [TBL] [Abstract][Full Text] [Related]
19. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Salven P; Orpana A; Joensuu H Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697 [TBL] [Abstract][Full Text] [Related]
20. Serum VEGF levels in women with a benign breast tumor or breast cancer. Salven P; Perhoniemi V; Tykkä H; Mäenpää H; Joensuu H Breast Cancer Res Treat; 1999 Jan; 53(2):161-6. PubMed ID: 10326793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]